Archives

Qventus: $105 Million (Series D) For AI-Based Health System Automation

By Amit Chowdhry ● Jan 16, 2025

Qventus, a provider of AI-based care automation software for health systems, announced a $105 million investment led by KKR, with additional participation from renowned investment firm Bessemer Venture Partners, and new strategic investors, including leading health systems Northwestern Medicine, HonorHealth, and Allina Health. And this funding follows a year of significant growth for Qventus, increasing its cadre of health system partners and expanding its team globally.

Labviva: $25 Million (Series B) Raised For Accelerating Life Sciences Product Development

By Amit Chowdhry ● Jan 16, 2025

Labviva, a leading AI procurement platform for life sciences, announced the closing of its $25 million Series B, bringing the total funding to $55 million. The round was led by 53 Stations, with continued participation from Biospring Partners, B Capital Group, and Glasswing Ventures. And the funding reflects the company’s boom growth and escalating demand in Biopharma for automated supply chain and procurement solutions. In connection with the funding round, 53 Station’s co-founder and Managing Partner, Jason Pritzker, will join Labviva’s Board of Directors.

Clear Labs: $30 Million (Series D) Secured For Advancing Development Of Sequencing Solutions

By Amit Chowdhry ● Jan 16, 2025

Clear Labs, a provider of fully automated and next-generation sequencing (NGS) platforms for turnkey diagnostics, announced it has raised $30 million in its Series D financing. This funding round was led by a strategic investor, along with participation from existing investors, including Counterpoint Global (Morgan Stanley), Felicis, GV, HBM Genomics, Khosla Ventures, Menlo Ventures, Nimble Ventures, Redmile Group, Wing Venture Capital, and funds and accounts advised by T. Rowe Price Associates.

Red Sky Health: $3 Million (Seed) Closed For Optimizing Healthcare Claims Management

By Amit Chowdhry ● Jan 16, 2025

Red Sky Health (RSH), an AI-based platform designed to optimize healthcare claims management, announced it has raised $3 million in seed funding. The funding round was led by serial entrepreneur and investor Trevor Burgess, along with notable alumni from Charles River Data, Gleb Drobkov, and Mike Dezube, now key figures in Neptune Flood's data science leadership.

Telix Buying Therapeutic Assets From ImaginAb For $45 Million

By Amit Chowdhry ● Jan 16, 2025

Telix Pharmaceuticals announced it has entered into an asset purchase agreement with antibody engineering company ImaginAb to buy a pipeline of next-generation therapeutic candidates, a proprietary novel biologics technology platform, and a protein engineering and discovery research facility to enhance existing innovation capabilities.

Lantheus To Buy Life Molecular Imaging For Upfront Payment Of $350 Million

By Amit Chowdhry ● Jan 16, 2025

Lantheus Holdings, a leading radiopharmaceutical-focused company committed to enabling clinicians to Find, Fight and Follow disease to deliver better patient outcomes, announced a definitive agreement to acquire Life Molecular Imaging in an all-cash transaction consisting of an upfront payment of $350 million and up to an additional $400 million in potential earn-out and milestone payments. And Life Molecular, a Life Healthcare Group Holdings subsidiary, is dedicated to advancing novel Positron Emission Tomography (PET) radiopharmaceutical diagnostics.

TPG: Kathy Elsesser Named As New Independent Director

By Amit Chowdhry ● Jan 16, 2025

Global alternative asset management firm TPG announced that Kathy Elsesser has joined its Board of Directors as an independent director, effective immediately.

DIRECTV Buys Majority Ownership In INVIDI Technologies

By Amit Chowdhry ● Jan 16, 2025

DIRECTV announced it acquired the majority ownership of INVIDI Technologies, a leader in addressable television advertising solutions that increase the value of advertising inventory for programmers and distributors by enabling marketers to target specific audiences on television without wasting ad impressions.

Clifford Chance: Bruce Embley Named As Private Equity Partner

By Amit Chowdhry ● Jan 16, 2025

Global law firm Clifford Chance announced the appointment of leading Private Equity Partner Bruce Embley, based in London, as part of the firm's ambitious global Private Capital growth strategy. And Embley brings extensive experience advising on high-profile and complex private capital transactions for market leading clients.

Aligned Data Centers Raises Over $12 Billion

By Amit Chowdhry ● Jan 16, 2025

Aligned Data Centers, a leading technology infrastructure company providing innovative, sustainable, and adaptive Scale Data Centers and Build-to-Scale solutions for global hyper-scale and enterprise customers, announced it has completed another funding round totaling over $5 billion of new primary equity and over $7 billion of new debt commitments to fund accelerated platform expansion and ongoing innovation.

Colossal: $200 Million (Series C) Raised At $10.2 Billion Valuation For De-Extinction Technology

By Amit Chowdhry ● Jan 16, 2025

De-extinction company Colossal Biosciences announced $200 million in a Series C funding round by TWG Global, jointly led by Mark Walter and Thomas Tull. And Colossal’s additional strategic investors include funds such as USIT, Animal Capital, Breyer Capital, At One Ventures, In-Q-Tel, BOLD Capital, Peak 6, and Draper Associates, and others and private investors including Robert Nelsen, Peter Jackson, Fran Walsh, Ric Edelman, Brandon Fugal, Paul Tudor Jones, Richard Garriott, Giammaria Giuliani, Sven-Olof Lindblad, Victor Vescovo, and Jeff Wilke.

Ubiety Technologies: $10 Million (Series A-1) Secured At $90 Million Valuation For Home Insights Platform

By Amit Chowdhry ● Jan 16, 2025

Ubiety Technologies announced that it has completed a $10 million Series A-1 financing. This funding will be used to enhance its product, accelerate the development of its proprietary AI engine, and expand go-to-market capabilities to meet the needs of its rapidly growing customer base.

Esphera SynBio: $2 Million (Seed) Funding Raised For Developing Nanomedicine Vaccines

By Amit Chowdhry ● Jan 16, 2025

Synthetic biology company Esphera SynBio announced the closing of a $2 million seed financing round. The funding builds on the company's advanced R&D activities and proceeds are directed at identifying an initial cancer vaccine clinical candidate and general corporate purposes. And seed investors GKCC and FACIT supported the financing.

Twentyeight Health: $10 Million (Series A) Secured To Advance Women’s Healthcare Platform

By Amit Chowdhry ● Jan 16, 2025

Twentyeight Health, a leading digital-first women's healthcare platform delivering convenient, affordable, and stigma-free reproductive and sexual care in 43 states, announced $10 million in Series A funding led by Seae Ventures, with participation from Impact America Fund, The Social Entrepreneurs' Fund, RH Capital, Impact Engine, Gratitude Railroad, and Townhall Ventures. And this brings the company's total funding to $25 million.